Business

Study Finds Cannabis May Increase False Memories

Researchers Examine THC’s Impact on Memory A new study from Washington State University suggests that cannabis may not only impair memory but also increase the likelihood of forming false memories...

Allbirds to Exit Footwear, Pivot to AI

$50 Million Convertible Financing Secured Allbirds announced it has entered into a definitive agreement with an institutional investor for...

Starbucks Debuts ChatGPT Drink Finder

AI Tool Aims to Spark Beverage Inspiration Starbucks has introduced a beta app within ChatGPT designed to help customers...

Nine Killed in Turkey School Shooting

Attack at Secondary School in Kahramanmaras At least eight students and one teacher were killed in a shooting at...

Oats Study Links Simple Diet to Lower LDL

Everyday Staple Shows Measurable Impact Cholesterol can rise silently over time, increasing the risk of cardiovascular disease even when...
spot_img

Spirit Airlines warns of survival risk

Carrier faces cash crunch months after bankruptcy exit Spirit Airlines has cautioned investors that its ability to operate over the next year is in doubt...

McDonald’s Earnings Beat Expectations on Menu Promotions

Value Deals Help Reverse U.S. Sales Declines McDonald’s reported stronger-than-expected earnings and revenue for the second quarter, as successful marketing campaigns and new menu items...

Gates Foundation Commits $2.5B to Women’s Health

Major Investment Targets Research Gaps The Bill & Melinda Gates Foundation announced a $2.5 billion commitment over the next five years to accelerate research in...

Palantir Eyes Oracle’s Throne in AI Boom

Wedbush Sees Massive Upside for PLTR Palantir Technologies has earned a top spot among the best-performing AI stocks of 2025. With growing momentum in artificial...

BP Unveils Largest Oil Discovery in 25 Years

Major Offshore Find in Brazil BP has announced its biggest oil and gas discovery in more than two decades following a successful drilling operation off...

Novo Nordisk Slumps After Downgrade and Weaker Outlook

Stock dips for third straight day amid revised guidance Novo Nordisk A/S (NYSE:NVO) extended its decline on Wednesday, falling 7.25% to close at $50.03 per...